Caitong International Asset Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.8K Sell
3,476
-8,437
-71% -$80.6K ﹤0.01% 832
2026
Q1
$109K Buy
11,913
+6,391
+116% +$53.6K 0.02% 555
2025
Q4
$41.1K Buy
5,522
+5,490
+17,156% +$39.5K 0.01% 781
2025
Q3
$214 Sell
32
-608
-95% -$4.22K ﹤0.01% 1659
2025
Q2
$4.24K Buy
640
+343
+115% +$2.43K ﹤0.01% 1083
2025
Q1
$2.72K Buy
+297
New +$2.97K ﹤0.01% 1227

Other funds holding BVS

Caitong International Asset Management's BVS Position: Q2 2026 in Review

Caitong International Asset Management reduced its Bioventus (BVS) stake by 71% in Q2 2026, selling an estimated $80.6K and leaving 3,476 shares worth $32.8K. The position accounts for ﹤0.01% of the portfolio, ranked #832.

Caitong International Asset Management first reported a position in BVS in Q1 2025 and has held it in 6 quarters since. The position peaked at $109K in Q1 2026. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Caitong International Asset Management held 3,476 shares of Bioventus worth $32.8K as of Q2 2026.
  • Caitong International Asset Management sold 8,437 Bioventus shares in Q2 2026, an estimated $80.6K.
  • Bioventus made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #832 holding.
  • Caitong International Asset Management first reported a position in Bioventus in Q1 2025 and has held it in 6 quarters since.
  • Caitong International Asset Management's Bioventus position peaked at $109K in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.